Patients with pneumonia from Covid 19 with at least one of the following comorbidities:
Hypertension
Obesity and/or type 2 diabetes
Cardiovascular disease
Chronic obstructive lung disease

Without any of the following comorbidities

Pneumonia, Viral

Hypertension

Diabetes Mellitus

Obesity

Cardiovascular Diseases

Obstructive Lung Disease

Fondazione Policlinico Universitario A. Gemelli IRCCS

Prognostic Factors Keeping Track for COVID-19 Pneumonia

Time of Recovery and Prognostic Factors of COVID-19 Pneumonia

mean rate of recovery in patients with diagnosis of Covid-19 pneumonia, who present with complications at the time of hospital admission (such as diabetes, obesity, cardiovascular disease, hypertension or respiratory failure), with the mean recovery rate in patients without any of the above-mentioned complications.

comparison of the survival curves (times to improvement) in the two groups (patients with and without complications) and among patients presenting with different types of complications

the efficacy of different pharmaceutical treatment against Covid-19

liver, kidney or multiorgan failure, cardiac failure

Geltrude Mingrone

Associate Professor of Internal Medicine

Catholic University of the Sacred Heart

Intranasal mupirocin ointment and sodium hypochlorite (bleach) baths

Intranasal petrolatum ointment treatment and plain water baths

Intranasal mupirocin ointment treatment and sodium hpochlorite (bleach baths)

Treatment

Placebo

Total

Sex: Female, Male

Region of Enrollment

The proportion of affected body surface area (BSA) was estimated from 4 designated body regions(head/neck, upper limbs, trunk, and lower limbs),and the Physician's Assessment of Individual Signs was determined for each region by grading signs of AD on a 4-point scale. Both the proportion of affected BSA and the Physician's Assessment of Individual Signs score were used to calculate the EASI score,a validated composite score that ranges from 0 (clear) to 72 (very severe).

Change in Eczema Area and Severity Index (EASI)Scores According to Location

Overall Study

Amy Paller, MD

Atopic Dermatitis

Sodium hypochlorite (bleach) baths twice weekly for 3 months

Sodium hypochlorite (bleach) baths

Intranasal mupirocin 2% ointment BID x five days (3 times total for subjects; one time only for family members)

Mupirocin ointment

Water baths twice weekly for three months

Water

Intranasal petrolatum ointment twice daily for five days

ceramide/durchfall

Prognostic Factors Keeping Track for COVID-19 Pneumonia

The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird